Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shot

Journal article

Inadequate booster uptake threatens the success of immunization campaigns as seen with the recently rolled-out R21 malaria vaccine. The ability to administer both prime and boost immunizations with a single injection would therefore save lives and alleviate health care burdens. We present a platform for delayed delivery of the booster dose that is scalable with existing technology, easily injectable, and protective against malaria in vivo. Using chip-based microfluidics, we encapsulated the R21 malaria vaccine in polymer microcapsules that release their content weeks to months postinjection. Coinjecting microcapsules with the priming dose of the R21 vaccine elicited strong antibody responses in a mouse model and provided 85% of the protection of a standard prime/boost schedule. If confirmed in humans, these results would pave the way for rapid deployment of single-shot prime/boost vaccination, an urgently needed global health intervention.

Authors: Guyon, R; Reinke, S; Truby, A; Sims, L; Hill, AVS

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: American Association for the Advancement of Science
• Journal: Science Translational Medicine
• Volume: 17
• Issue: 804
• Article number: eadw2256
• Publication date: 2025-06-25
• Acceptance date: 2025-04-24
• DOI: 10.1126/scitranslmed.adw2256
• EISSN: 1946-6242
• ISSN: 1946-6234
• Language: English
• Keywords: vaccination; capsules; immunization; secondary; animals; malaria; malaria vaccines